Experience the Quality With Free CCP-C Exam Questions That Helps Candidates Pass

HFNC provides warmed, humidified high flow that reduces work of breathing, washes out dead space, and offers mild distending pressure—preferred first escalation in bronchiolitis. Immediate intubation (A) is reserved for failure or impending apnea. A dry high-flow mask (C) is uncomfortable and ineffective. Opioids (D) risk respiratory depression. Use age-appropriate cannula size, close monitoring, suctioning, and hydration; be ready to escalate to CPAP/intubation if hypoxemia or fatigue progresses. Maintain thermoregulation and minimize agitation to reduce oxygen demand during transport.

Pancreatitis triggers a systemic inflammatory cascade that increases pulmonary capillary permeability, producing protein-rich edema and diffuse alveolar damage—central to ARDS physiology. The result is shunt and severe V/Q mismatch with refractory hypoxemia and reduced compliance; PaO₂/FiO₂ ≤300 supports ARDS (here moderate at 135). Hydrostatic edema (A) would correlate with elevated left-sided filling pressures and often improves with diuresis; echo indicates normal LV function. Massive PE (C) mainly increases alveolar dead space with abrupt hemodynamic compromise rather than diffuse opacities. Pure airway obstruction (D) yields hyperinflation and increased resistance, not the stiff, noncompliant lungs typical of ARDS. Transport priorities: lung-protective ventilation (VT 4–6 mL/kg PBW), plateau ≤30, adequate PEEP, permissive hypercapnia, consideration of prone positioning and short-course neuromuscular blockade for severe dyssynchrony. Avoid fluid overload; use ultrasound to guide volume and monitor for evolving effusions.

Elevated PCWP (18) with low cardiac output and high SVR indicates left-sided failure (cardiogenic shock). CVP is not elevated, making RV infarction (A) less likely. Distributive shock (C) typically has low SVR and normal/low filling pressures. Hypovolemia (D) usually shows low CVP and PCWP with high SVR but often normal or high heart rate and improved CO after fluids. CCP-C management: inotropes (e.g., dobutamine), careful vasopressor use (norepinephrine) to maintain MAP, diuresis if pulmonary edema severe once perfusion is adequate, and rapid coordination for revascularization/mechanical support. Monitor for arrhythmias and ischemia; titrate therapy to perfusion endpoints (MAP, urine output, lactate).

Low-dose ketamine provides potent analgesia via NMDA antagonism, is opioid-sparing, preserves respiratory drive, and typically maintains hemodynamics—ideal for trauma with persistent pain and dyssynchrony. High-dose benzodiazepines (A) cause delirium and hypotension without analgesia. Propofol boluses (C) risk hypotension. NSAID monotherapy (D) is inadequate and may be contraindicated (bleeding/renal risk). Start ketamine after a small bolus if needed, monitor for hypersalivation (treatable with anticholinergic), and continue multimodal analgesia (acetaminophen ± regional at destination). Reassess sedation targets (RASS) and synchrony frequently; improved analgesia often reduces ventilator fighting and catecholamine surge.

Positioning the healthier lung dependent increases perfusion to the better-aerated lung, improving V/Q matching and oxygenation. “Good lung up” (B) favors perfusion toward the diseased side. Trendelenburg (C) risks aspiration and reduces FRC. Zero PEEP (D) promotes collapse and worsens shunt. Secure airway/lines before turning, pad pressure points, and continuously monitor SpO₂, BP, and EtCO₂ because position changes alter preload and gas exchange. Combine with appropriate PEEP/FiO₂ and secretion management; reassess frequently to ensure sustained benefit and hemodynamic stability during transport.